You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Deucravacitinib

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lichen Planopilaris Trial in Scottsdale, Jacksonville (Deucravacitinib)

Not yet recruiting
  • Lichen Planopilaris
  • Deucravacitinib
  • Scottsdale, Arizona
  • +1 more
Oct 16, 2023

Palmoplantar Pustulosis Trial (Deucravacitinib)

Not yet recruiting
  • Palmoplantar Pustulosis
  • Deucravacitinib
  • (no location specified)
Feb 1, 2023

Pyoderma Gangrenosum Trial in Lebanon (Deucravacitinib)

Not yet recruiting
  • Pyoderma Gangrenosum
  • Deucravacitinib
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Apr 6, 2023

Inflammatory Epidermal Genodermatoses Trial in Nice (deucravacitinib)

Not yet recruiting
  • Inflammatory Epidermal Genodermatoses
  • deucravacitinib
  • Nice, Chu de Nice, France
    DRCI
Nov 24, 2023

Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)

Not yet recruiting
  • Psoriasis Vulgaris
  • deucravacitinib
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Plaque Psoriasis Trial (JNJ-77242113, JNJ-77242113 Matching Placebo, Deucravacitinib)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Nov 16, 2023

Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in

Recruiting
  • Plaque Psoriasis
  • Deucravacitinib
  • Selters, Rhineland-Palatinate, Germany
    Dermatologische Spezial- und Schwerpunktpraxis Selters
Oct 23, 2023

Hidradenitis Suppurativa Trial in Boston (Deucravacitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • Deucravacitinib
  • Placebo
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 10, 2023

Psoriasis Trial in Winston-Salem (Text reminder)

Not yet recruiting
  • Psoriasis
  • Text reminder
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences Department of Dermatology
Jan 31, 2023

Nail Psoriasis Trial (Deucravacitinib)

Not yet recruiting
  • Nail Psoriasis
  • Deucravacitinib
  • (no location specified)
Dec 8, 2022

Compare Effectiveness of Deucravacitinib Vs Apremilast in Plaque

Recruiting
  • Psoriasis
    • Waltham, Massachusetts
      Local Institution
    Feb 15, 2023

    Assess Deucravacitinib Post-marketing Surveillance in Psoriasis

    Not yet recruiting
    • Psoriasis
      • Tosima-ku, Tokyo, Japan
        Local Institution
      Nov 22, 2022

      Psoriasis Trial in Germany, Poland, United States (Deucravacitinib, Placebo)

      Not yet recruiting
      • Psoriasis
      • Deucravacitinib
      • Placebo
      • Indianapolis, Indiana
      • +3 more
      Jul 27, 2022

      Healthy Participants Trial in Miami, Austin (Deucravacitinib, Famotidine)

      Completed
      • Healthy Participants
      • Miami, Florida
      • +1 more
      Feb 24, 2022

      Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)

      Not yet recruiting
      • Sjögren's Syndrome
      • Deucravacitinib
      • Placebo
      • Santa Monica, California
      • +25 more
      Jul 19, 2023

      Plaque Psoriasis Trial in Worldwide (Deucravacitinib, Placebo matching deucravacitinib)

      Recruiting
      • Plaque Psoriasis
      • Deucravacitinib
      • Placebo matching deucravacitinib
      • Sydney, New South Wales, Australia
      • +20 more
      Jul 1, 2022

      Alopecia Areata Trial in Worldwide (Deucravacitinib, Placebo)

      Recruiting
      • Alopecia Areata
      • Deucravacitinib
      • Placebo
      • Irvine, California
      • +22 more
      Jan 31, 2023

      Palmoplantar Psoriasis, Genital Psoriasis Trial in Worldwide (Deucravacitinib, Placebo)

      Not yet recruiting
      • Palmoplantar Psoriasis
      • Genital Psoriasis
      • Deucravacitinib
      • Placebo
      • Birmingham, Alabama
      • +24 more
      Sep 12, 2023

      Psoriasis Trial in United States (Deucravacitinib, Placebo)

      Not yet recruiting
      • Psoriasis
      • Deucravacitinib
      • Placebo
      • Phoenix, Arizona
      • +24 more
      Jan 26, 2023

      Crohn Disease, Ulcerative Colitis Trial in Worldwide (Deucravacitinib)

      Recruiting
      • Crohn Disease
      • Ulcerative Colitis
      • Deucravacitinib
      • Suwanee, Georgia
      • +47 more
      Jan 17, 2023

      Lupus Erythematosus, Discoid, Lupus Erythematosus, Subacute Cutaneous Trial in Worldwide (Deucravacitinib, Placebo)

      Recruiting
      • Lupus Erythematosus, Discoid
      • Lupus Erythematosus, Subacute Cutaneous
      • Deucravacitinib
      • Placebo
      • Los Angeles, California
      • +42 more
      Oct 21, 2022

      Healthy Volunteers Trial in Nottingham (Reference Treatment- BMS-986165-01, Prototype BMS-986165, Famotidine)

      Completed
      • Healthy Volunteers
      • Reference Treatment- BMS-986165-01
      • +3 more
      • Nottingham, United Kingdom
        Quotient Sciences Miami
      Oct 5, 2021

      Healthy Participants Trial in Lenexa (BMS-986165, Metformin)

      Completed
      • Healthy Participants
      • Lenexa, Kansas
        PRA Health Sciences - Lenexa
      Nov 9, 2021

      Systemic Lupus Erythematosus Trial in Worldwide (Deucravacitinib, Placebo)

      Recruiting
      • Systemic Lupus Erythematosus
      • Deucravacitinib
      • Placebo
      • Anniston, Alabama
      • +88 more
      Jan 25, 2023

      Systemic Lupus Erythematosus Trial in Worldwide (Deucravacitinib, Placebo)

      Recruiting
      • Systemic Lupus Erythematosus
      • Deucravacitinib
      • Placebo
      • La Jolla, California
      • +91 more
      Jan 24, 2023